LAMISIL AT- terbinafine hydrochloride spray 
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC

----------

Drug Facts

Active ingredient

Terbinafine hydrochloride

Purpose

Antifungal

Uses

cures most jock itch (tinea cruris)
relieves itching, burning, cracking, and scaling which accompany this condition

Warnings

For external use only

Do Not Use

on nails or scalp
in or near the mouth or the eyes
for vaginal yeast infections

When using this product

do not get into eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor

if too much irritation occurs or gets worse.

Keep Out of Reach of Children

If swallowed, get medical help or contact a poison control

center right away.  

Directions

adults and children 12 years and over
wash the affected area with soap and water and dry completely before applying
spray affected area once a day (morning or night) for 1 week or as directed by a doctor
wash hands after each use
children under 12 years: ask a doctor

Other information

store at 8 - 25° C (46 - 77° F)

Additional Information

Full Prescription Strength

For Effective Relief of: ° Itching ° Burning

Distr. By:  

 
Novartis Consumer Health, Inc.
 
Parsippany, NJ 07054-0622 ©2006

Inactive ingredients

cetomacrogol, ethanol, propylene glycol, purified water USP

Questions

call 1-800-452-0051 24 hours a day, 7 days a week

Principal Display

Carton Image
LAMISIL AT 
terbinafine hydrochloride spray
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0067-4000
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TERBINAFINE HYDROCHLORIDE (UNII: 012C11ZU6G) (TERBINAFINE - UNII:G7RIW8S0XP) TERBINAFINE HYDROCHLORIDE1 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
ALCOHOL (UNII: 3K9958V90M)  
CETETH-20 (UNII: I835H2IHHX)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0067-4000-0130 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/01/200007/24/2015
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02112405/01/200007/24/2015
Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263)

Revised: 12/2018
 
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC